Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 677Neoplasms 593Colorectal Neoplasms 292Carcinoma, Non-Small-Cell Lung 292Prostatic Neoplasms 281Lung Neoplasms 223Melanoma 161Multiple Myeloma 150Neoplasm Metastasis 146Head and Neck Neoplasms 143Pancreatic Neoplasms 141Ovarian Neoplasms 133Carcinoma, Hepatocellular 126Leukemia, Myeloid, Acute 123Colonic Neoplasms 112Brain Neoplasms 112Squamous Cell Carcinoma of Head and Neck 111Uterine Cervical Neoplasms 108Stomach Neoplasms 105Recurrence 101Lymphoma 101Glioblastoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Lymphoma, Non-Hodgkin 82Hematologic Neoplasms 80Urinary Bladder Neoplasms 78Lymphoma, Follicular 78Glioma 75Parkinson Disease 4, Autosomal Dominant Lewy Body 74Leukemia, Lymphocytic, Chronic, B-Cell 72

Interventions

radium Ra 223 dichloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bone Metastatic Castration-resistant Prostate Cancer × 1 year × Clear all
NCT04521361 2025-09-19

A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Bayer

Phase 1 Completed
46 enrolled
Genitourinary

Bone Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡